estelle-35 ed
douglas pharmaceuticals limited - cyproterone acetate 2mg; ; ethinylestradiol 0.035mg; - film coated tablet - active: cyproterone acetate 2mg ethinylestradiol 0.035mg excipient: croscarmellose sodium lactose monohydrate magnesium stearate microcrystalline cellulose opadry buff oy-3690 opadry white y-1r-7000b opaglos white 6000 povidone purified water quinoline yellow sucrose lactose monohydrate magnesium stearate microcrystalline cellulose - estelle-35 and estelle-35 ed are indicated for the treatment of androgen dependent diseases in women, such as acne (where oral antibiotics or local treatment alone has not been successful), especially pronounced forms and those which are accompanied by seborrhoea or by inflammation or formation of nodes (acne papulopustulosa, acne nodulocystica), androgenic alopecia, mild forms of hirsutism. estelle-35 and estelle-35 ed are also indicated for oral contraception in women requiring treatment for these androgen-dependent diseases; it is not recommended in women solely for contraception. estelle-35 and estelle-35 ed are also indicated for treating the symptoms of polycystic ovary syndrome.
dianette 2mg/35 microgram coated tablets
bayer limited - cyproterone acetate; ethinylestradiol ph.eur. - coated tablet - 2/35 milligram(s) - antiandrogens and estrogens; cyproterone and estrogen
dianette 2/35 mg/mcg coated tablets
clear pharma limited - cyproterone acetate, ethinylestradiol - coated tablets - 2/35 mg/mcg - antiandrogens and estrogens
diane-35 tablet
bayer (south east asia) pte ltd - cyproterone acetate; ethinylestradiol - tablet, sugar coated - 2 mg - cyproterone acetate 2 mg; ethinylestradiol 0.035 mg
on.setron-denk 8mg odt tablets orodispersible
denk pharma gmbh & co. kg - ondansetron - tablets orodispersible - 8mg
on.setron-denk 8mg odt tablets orodispersible
denk pharma gmbh & co. kg - ondansetron - tablets orodispersible - 8mg
depalept 500 enteric coated tablets
cts chemical industries ltd, israel - valproic acid as sodium - tablets enteric coated - valproic acid as sodium 500 mg - valproic acid - valproic acid - generalized or partial epilepsy, secondary generalized epilepsy, mixed forms of epilepsy.
depalept syrup
cts chemical industries ltd, israel - valproic acid as sodium - syrup - valproic acid as sodium 40 mg/ml ml - valproic acid - valproic acid - generalized or partial epilepsy secondary generalized epilepsy and mixed forms of epilepsy.
depalept 200 mg
cts chemical industries ltd, israel - valproic acid as sodium - tablets enteric coated - valproic acid as sodium 200 mg - valproic acid - valproic acid - anti-epileptic.
depalept oral solution
cts chemical industries ltd, israel - valproic acid as sodium - solution (oral) - valproic acid as sodium 200 mg/ml - valproic acid - treatment of generalized or partial epilepsy secondary generalized epilepsy and mixed forms of epilepsy.